RUVBL1 and cancer: Tommaso Mello (Florence, Italy), in collaboration with Oksana Bereschenko (Perugia, Italy) (Bereshchenko et al., 2012), investigated the onset and progression of hepatocellular carcinoma using a hepatocyte-conditional Pontin+/− mouse model and the Diethylnitrosamine cancer induction protocol.